USP24 is a cross-reactive DUB targeting MOV10 to regulate IFN-I production
The type I Interferon (IFN-I)-induced ubiquitin-like modifier Interferon-Stimulated Gene 15 (ISG15) plays a crucial role in the innate immune response against viral infections. ISG15 is conjugated to target proteins by an enzymatic cascade, called ISGylation. While ubiquitin-specific protease 18 (USP18) serves as the major deISGylase counteracting ISG15 conjugation, ISG15 cross-reactive deubiquitylating enzymes (DUBs) have also been reported. Here, we identify USP24 as an ISG15 cross-reactive DUB through activity-based protein profiling. USP24 processes pro-ISG15 and ISG15-linked substrates in vitro, and its depletion increases ISG15 conjugates following interferon stimulation in cells without altering canonical IFN-I signaling. USP24 knockout cells show increased IFN-β and ISG expression upon activation of cytosolic RNA sensing via viral mimicry. Proteomic analysis identifies RNA helicase Moloney leukemia virus 10 (MOV10) as a specific target of USP24 for deISGylation. Our data revealed that ISGylation of MOV10 promotes MOV10 interaction with IFIT3 and enhances IFN-β production/secretion in response to viral stimuli. This process is negatively regulated by USP24, which directly deISGylates MOV10. Our data highlight USP24's role in modulating ISGylation and IFN-I production, suggesting USP24 as a potential therapeutic agent for infectious and inflammatory diseases.
Authors
- Annemarthe G. van der Veen (ORCID: https://orcid.org/0000-0001-9324-3404)
- Ayşegül Sapmaz (ORCID: https://orcid.org/0000-0003-3942-7602)
- Benedikt Mathias Kessler (ORCID: https://orcid.org/0000-0002-8160-2446)
- Adán Pinto-Fernández (ORCID: https://orcid.org/0000-0003-1693-9664)
- Klaus‐Peter Knobeloch (ORCID: https://orcid.org/0000-0003-1587-1944)
- Paul P. Geurink (ORCID: https://orcid.org/0000-0003-1849-1111)
- Sonia Zúñiga (ORCID: https://orcid.org/0000-0003-2549-6826)
- Marjolein Kikkert (ORCID: https://orcid.org/0000-0002-5779-7386)
- Timo Oosenbrug (ORCID: https://orcid.org/0000-0002-7533-0595)
- Robbert Q. Kim (ORCID: https://orcid.org/0000-0003-1834-8673)
- Jimmy J.L.L. Akkermans (ORCID: https://orcid.org/0000-0002-8000-7952)
- Rishov Mukhopadhyay (ORCID: https://orcid.org/0000-0002-8972-8983)
- Simeon D. Draganov (ORCID: https://orcid.org/0000-0002-8695-3499)
- G. Fritz (ORCID: https://orcid.org/0000-0002-4571-8812)
- María Guzmán (ORCID: https://orcid.org/0000-0002-3866-5222)
Institutions
- University of Hohenheim (DE)
- University of Freiburg (DE)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Leiden University Medical Center (NL)
- University of Oxford (GB)
- Centro Nacional de Biotecnología (ES)
Publication Details
- Journal
- Nature Communications
- Published
- 2026-06-19
- DOI
- https://doi.org/10.1038/s41467-026-74490-2
- Primary Topic
- interferon and immune responses
- Type
- article
- Field-Weighted Citation Impact
- 0.00